Table 3. Characteristics of Patient Survey Respondents.
| Characteristic | MD Support (nā=ā46), No. (%) |
|---|---|
| AMD diagnosis | |
| Yes | 35 (76) |
| Dry (nonexudative, nonneovascular) AMD | 12 (26) |
| Wet (exudative, neovascular) AMD | 23 (50) |
| None/no response | 11 (24) |
| Time since AMD diagnosis,a y | |
| <1 | 3 (7) |
| 1-5 | 9 (20) |
| 5-10 | 9 (20) |
| >10 | 14 (30) |
| Sexb | |
| Female | 28 (61) |
| Male | 9 (20) |
| Age, yb | |
| <70 | 11 (24) |
| 70 to <80 | 17 (37) |
| ā„80 | 9 (20) |
| Race/ethnicityb,c | |
| White | 37 (80) |
| American Indian or Alaska Native | 1 (2) |
| Hispanic originb | |
| No | 37 (80) |
| Yes | 0 |
| Country of residenceb,c | |
| United States | 35 (76) |
| Outside the United States | 7 (15) |
| Highest level of educationb | |
| No 4-y college degree | 11 (24) |
| Bachelor's degree | 14 (30) |
| Graduate or professional degree | 12 (26) |
| Participation in a randomized clinical triald | |
| None | 31 (67) |
| At least 1 | 5 (11) |
| Use systematic reviews to make treatment decisionsd | |
| No | 14 (30) |
| Yes | 18 (39) |
| Not sure | 4 (9) |
Abbreviation: AMD, age-related macular degeneration.
a
No response for 11 of 46 survey participants.
b
No response for 9 of 46 survey participants.
c
Multiple answers allowed; total percentages may add to more than 100.
d
No response for 10 of 46 survey participants.